Preventing of GVHD with Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Ruxolitinib At Children and Young Adults with Hemoblastosis

Clinical trial NCT06756152 · RECRUITING

Trial details

NCT number: NCT06756152
Sponsor: Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Biphenotypic Acute Leukemia Acute Lymphoblastic Leukemia Myeloblastic Leukemia Bilinear Leukemia Malignant Lymphoma, Non-Hodgkin Myelodysplastic Syndrome

Start date: 2024-07-10
Primary completion: 2026-07-10
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.